BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32255282)

  • 1. TPM1 is a Novel Predictive Biomarker for Gastric Cancer Diagnosis and Prognosis.
    Hu L; Fang L; Zhang ZP; Yan ZL
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
    Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
    Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA‑183‑5p.1 promotes the migration and invasion of gastric cancer AGS cells by targeting TPM1.
    Lin J; Shen J; Yue H; Cao Z
    Oncol Rep; 2019 Dec; 42(6):2371-2381. PubMed ID: 31638242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and tumor significance of tropomyosin-1 expression levels in renal cell carcinoma.
    Wang J; Guan J; Lu Z; Jin J; Cai Y; Wang C; Wang F
    Oncol Rep; 2015 Mar; 33(3):1326-34. PubMed ID: 25607530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
    Zhang J; Dai WJ; Yang XZ
    Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker.
    Zare M; Hadi F; Alivand MR
    Per Med; 2018 Sep; 15(5):361-370. PubMed ID: 30259780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
    Jiang H; Yu WW; Wang LL; Peng Y
    Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
    Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
    Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
    Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
    Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dickkopf-1 expression is a novel prognostic marker for gastric cancer.
    Gao C; Xie R; Ren C; Yang X
    J Biomed Biotechnol; 2012; 2012():804592. PubMed ID: 22496615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.
    Zhou WH; Tang F; Xu J; Wu X; Feng ZY; Li HG; Lin DJ; Shao CK; Liu Q
    BMC Cancer; 2011 Sep; 11():397. PubMed ID: 21933426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
    Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of Tensin4 expression in human gastric cancer.
    Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
    Ann Surg Oncol; 2008 Sep; 15(9):2606-13. PubMed ID: 18612693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of FIBCD1 Is Predictive of Poor Prognosis in Gastric Cancer.
    Jiang C; Zhu J; Zhou P; Zhu H; Wang W; Jin Q; Li P
    Am J Clin Pathol; 2018 Apr; 149(6):474-483. PubMed ID: 29659669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
    Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
    Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
    Chen H; Tian X; Luan Y; Lu H
    Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.